Please Wait

Applying Filters...

Cefuroxime Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

34 API Suppliers, 14 USDMF, 14 CEP/COS, 6 EU WC, 1 KDMF, 1 NDC API, 12 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

214 FDF Dossiers, 35 FDA Orange Book, 70 Europe, 2 Canada, 8 Australia, 52 South Africa, 47 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 7.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 30MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 Actylis, 1 Kerry, 1 Microlex e.U, 1 Pluviaendo, 1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Parenteral, 2 Fillers, Diluents & Binders, 1 Taste Masking, 1 Co-Processed Excipients

DIGITAL CONTENT

1 NEWS #PharmaBuzz

1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

35 Finished Drug Prices

35 Finished Drug Prices

MARKET PLACE

11 APIs, 5 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Sandoz completes acquisition of GSK’s cephalosporin business

11 Oct 2021

// Iona Everson PMLIVE

Contact us
to update this info

Cefuroxime Sodium

Cefuroxime Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

34 API Suppliers

14 USDMF

14 CEP/COS

6 EU WC

1 KDMF

1 NDC API

12 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

214 FDF Dossiers

35 FDA Orange Book

70 Europe

2 Canada

8 Australia

52 South Africa

47 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 7.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 30MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 Actylis

1 Kerry

1 Microlex e.U

1 Pluviaendo

1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Parenteral

2 Fillers, Diluents & Binders

1 Taste Masking

1 Co-Processed Excipients

DIGITAL CONTENT

1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

35 Finished Drug Prices

MARKET PLACE

11 APIs

5 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM

1 USP

1 Others

ANALYTICAL

1 BioAnalytical Methods

Filters

INJECTABLE;INJECTION - EQ 1.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 7.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons